The Effect of Proton Pump Inhibitor (PPI) on Plasma 5-Hydroxytryptamine (5-HT) Levels in Patients With Functional Dyspepsia (FD): a Double-Blind Randomized Control Trial

Trial Profile

The Effect of Proton Pump Inhibitor (PPI) on Plasma 5-Hydroxytryptamine (5-HT) Levels in Patients With Functional Dyspepsia (FD): a Double-Blind Randomized Control Trial

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Jun 2013

At a glance

  • Drugs Esomeprazole (Primary)
  • Indications Dyspepsia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 27 Jun 2013 New trial record
    • 18 May 2013 Results presented at the Digestive Disease Week 2013.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top